Search
Favorite Blogs
CAFC holds all the claims of a patent have the same expiration date, whether the claims are drawn to the product subject to patent term extension or not
| April 11, 2012
Genetics Institute, LLC v. Novartis Vaccines and Diagnostics, Inc.
August 23, 2011
Panel: Lourie, Plager and Dyk. Opinion by Judge Lourie. Concurrence-in-part and dissent-in part by Dyk.
Summary:
Today, we bring you the second in a series of three articles regarding an important case from last year. For part 1, click here. This article discusses the following question:
Question: Where a patent has been granted an extension of term due to regulatory review, is there a different expiration date for the claims that were the subject to the regulatory review and the claims that do not claim the approved product?
Answer: The expiration date is not determined on a claim by claim basis.
A patent, and therefore all of the claims in the patent, have the same expiration date, which is the expiration date as extended by patent term extension.
Category: Case Summary, Patent Term
Tags: Delay due to regulatory review > Expiration > FDA > patent term > Patent Term Extension > PTE
Tags: Delay due to regulatory review > Expiration > FDA > patent term > Patent Term Extension > PTE
Subscribe | 登録
Archives
Tags
- “DuPont Factors” Test
- § 101
- § 271(a)
- §101
- §102
- §102(b)
- §103
- §112
- §112 sixth paragraph
- §120
- §251
- §271(f)(1)
- §271(f)(2)
- §284
- §292
- 101
- 102(g)
- 112 6th paragraph
- 112 sixth paragraph
- 112(f)
- 15 U.S.C. § 1052(a)
- 15 U.S.C. § 1117(a)
- 15 U.S.C. Section 1052(f)
- 271(e)
- 28 U.S.C. §1391
- 28 U.S.C. §1400
- 35 U.S.C. § 101
- 35 U.S.C. § 102(b)
- 35 U.S.C. § 112
- 35 U.S.C. § 251
- 35 U.S.C. § 285
- 35 U.S.C. § 315(c)
- 35 U.S.C. §100
- 35 U.S.C. §101
- 35 U.S.C. §102
- 35 U.S.C. §103
- 35 U.S.C. §112
- 35 U.S.C. §120
- 35 U.S.C. §145
- 35 U.S.C. §284
- 35 U.S.C. §285
- 35 U.S.C. §314(d)
- 35 U.S.C. §315(b)
- 35 U.S.C. 112 ¶ 1
- 35 U.S.C. 112 ¶ 2
- 35 U.S.C. 156
- 35 U.S.C. Section 101
- 35 USC 314(d)
- 35 USC 324(e)
- A-delay
- abandoned
- abandoned suppressed or concealed
- abandonment
- abstract
- abstract idea
- abstract ideas
- abuse of discretion
- accounting
- acquired distinctiveness
- administrative patent judge
- Administrative Procedure Act
- affidavit
- Agreement to Agreement
- AIA
- algorithm
- Alice
- Alice Corp.
- all elements rule
- amendments
- America Invents Act
- amount
- Analogous Art
- ANDA
- ANDA litigation
- antecedent basis
- anticipation
- antitrust
- app
- apparatus
- appeal
- appeal of decision whether to institute IPR
- appointment clause
- arbitration
- Aristocrat
- article of manufacture
- artificial intelligence
- assignment
- assignment in writing requirement
- attorney fees
- Attorneys’ Fees
- automated process
- basic and novel properties
- basic knowledge
- best mode
- bifurcated infringement
- bilski
- biotech
- BPAI
- BRI
- Broadening
- broadening reissue
- broadest reasonable interpretation
- burden of persuasion
- burden of proof
- Burden Shifting
- business method
- but-for test
- cancellation
- capable of
- case or controversy
- Causal Nexus
- CBM
- cDNA
- certificate of correction
- claim
- claim amendments
- claim broadening
- claim charts
- Claim Construcrtion
- claim construction
- Claim Construction during IPR
- claim context
- claim differentiation
- claim interpretation
- Claim Preclusion
- claim scope
- claims as originally filed
- claims construction
- claims drafting
- claims limited by title and specification
- clear and convincing standard
- clear error
- clinical trial
- close
- CLS Bank
- co-inventors
- Collateral Estoppel
- colorable-differences
- commercial exploitation
- commercial success
- common assignees
- common knowledge
- common ownership
- common sense
- comparative results
- computer
- computer aided method
- computer memory
- computer patents
- computer product
- computer system
- computer-implemented means-plus-function
- concealed
- concealment
- conception
- confidential use
- confidentiality
- confidentiality agreement
- consisting essentially of
- Constitutional Law
- contempt
- context
- continuation
- continuation application
- continuation-in-part
- Continuation-in-part-application
- contract
- contributory infringement
- control
- conversion of units or parameters
- Covered Business Method
- Covered Business Method (CBM)
- Covered Business Method (CBM) Patent Review
- CPU
- critical date
- critical range
- criticality of ranges
- cross-appeal
- DABUS
- damage
- damages
- Data Manipulation
- de novo
- de novo review
- declaration
- declaration and affidavit
- Declaratory judgment
- definiteness
- Delay due to regulatory review
- design
- Design Patent
- design patents
- diagnostic methods
- diagnostics
- Dilution
- direct infringement
- disavowal
- Disavowal of Claim Scope
- disclaimer
- disclosure-dedication doctrine
- divided infringement
- divisional
- divisional application
- DJ Jurisdiction
- DNA
- doctrine of equivalent
- doctrine of equivalents
- domestic benefit
- domestic industry
- double patenting
- drawings
- Due process
- Earliest effective date
- effective filing date
- egregious conduct
- election of species
- eligibility
- eligible subject matter
- employee
- employee testimony
- employment contract
- en banc
- enablement
- enabling disclosure; burden of proof
- enhanced damages
- entire market value
- entire market value rule
- Equitable estoppel
- Error Without Deceptive Intent
- estoppel
- evidence
- evidence of secondary considerations
- evidence to overcome presumption of enablement
- exceptional case
- Exceptional Cases
- exclusion of embodiment
- experimental use
- expert declaration
- expert declarations
- expert testimony
- expert witness
- expert witness fees
- Expiration
- expired patent
- extraterritoriality
- extrinsic evidence
- extrinsic vs. intrinsic evidence
- False marking
- FDA
- FDA regulatory review
- figure
- filing date
- financial
- First Amendment
- first-to-file
- first-to-invent
- Foreign Priority
- forfeiture
- fraud
- FRCP 60(b)(3)
- functional aspect
- functional claim language
- functional claim limitations
- functional claiming
- functional language
- functional limitation
- Functional method claim
- Functionality
- galaxy nexus
- general industry skepticism
- General Knowledge
- Generics
- genus
- genus-species
- geographical indication
- geographically misdescriptive
- good-faith
- hardware
- hatch-waxman
- hybrid claiming
- IDS
- Incorporation by reference
- incorportion
- indefiniteness
- indefiniteness; claim construction; standard of review
- indirect infringement
- indispensable party
- induced inf
- induced infringement
- inducement
- ineligible subject matter
- inequitable conduct
- information disclosure statement
- information disclosure statement (IDS)
- infringement
- Infringement under the Doctrine of Equivalents
- Inherency
- injunction
- injunctions
- institution
- intended purpose
- intended use
- intent
- Intent of Parties
- intent to deceive
- Intentional Surrender
- Inter Partes Reexamination
- inter partes review
- interference
- International Trade Commission (“ITC”)
- internet
- interpretation
- interpretation of a reference
- intervening rights
- intrinsic evidence
- invalidity
- inventive concept
- Inventor's agreements
- inventorship
- inventorship correction
- IPR
- irreparable harm
- issuance date
- Issue Preclusion
- JMOL
- Joinder
- joint inventors
- joint inventorship
- joint/divided infringement
- judgment on the pleadings under FRCP 12(c)
- jurisdiction
- Kessler Doctrine
- known in the art
- KSR
- laboratory technique
- laches
- Lanham Act Section 2(a)
- law of nature
- law-of-the case doctrine
- laws of nature
- lead compound
- legal fees
- lexicographer
- license
- licensee
- licensing
- licensing agreement
- light-emitting diodes
- Likelihood of Confusion under 15 U.S.C. § 1052(d)
- likelihood of success
- literal infringement
- makes
- malpractice
- mandate rule
- marking
- markush group
- materiality
- maternal serum or blood
- mathematical formula
- Mayo
- Mayo test
- Mayo/Alice Test
- Mean-Plus-Function
- means
- Means for
- means plus function
- means-plus function
- means-plus-function
- mental process
- method
- method claims
- misrepresentation of prior art knowledge
- mistake
- mobile app
- modification
- molecular weight
- motion to amend
- Motion to Dismiss
- Motion to Stay
- Motion to Submit supplemental information
- Motivation
- motivation to combine
- MPF
- multiple embodiments
- Myriad
- Narrowing
- natural law
- NDA
- negative limitation
- New Ground of Rejection
- new matter
- nexus
- non practicing entities
- non-disclosure agreement
- non-enablement
- non-enabling prior art
- non-infringement opinion
- non-patent literature
- notice
- Notice and Opportunity to Respond
- novelty
- npe
- nucleotide
- objective indicia of nonobviousness
- objective recklessness
- obvious to try
- obviousness
- Obviousness of ranges
- obviousness-type double patenting
- offers to sell
- office action
- Official Notice
- on sale bar
- ongoing royalty
- online periodical
- open-ended claim range
- operability
- or sells; within the United States.”
- ordinary and
- ordinary and customary meaning
- ordinary meaning
- original patent requirement
- overlap
- own lexicographer
- ownership
- parallel litigation
- patent eligibility
- patent eligible subject matter
- patent exhaustion
- patent ineligible
- patent ineligible abstract idea
- patent ineligible subject matter
- patent infringement
- patent invalidation
- patent invalidity
- patent marking
- patent ownership
- patent term
- Patent Term Adjustment
- Patent Term Adjustment (PTA)
- Patent Term Extension
- Patent Trial and Appeal Board (PTAB)
- patent venue
- patent-eligible subject matter
- patentability
- patentable subject matter
- PCT application
- permanent injunction
- personal jurisdiction
- personalized treatment methods
- Petition
- Petitioner's burden in IPR
- physical phenomena
- possession
- Post Grant Review
- pre-AIA
- preamble
- preamble-within-a-preamble
- predictable
- preemption
- prejudice
- prejudicial treatment
- preliminary injunction
- prenatal diagnosis
- preparation
- preponderance of evidence
- presumption of enablement
- presumption of validity
- prima facie case of obviousness
- Primary Reference
- principle operation
- printed publication
- printed publications
- prior art
- prior inventor
- priority
- Problem to be Solved
- procedural issues
- process
- Process Conditions
- process limitation
- processor
- product of nature
- product-by- process claim
- product-by-pass claims
- product-by-process claims
- prosecution argument
- prosecution disclaimer
- prosecution history
- prosecution history disclaimer
- prosecution history estoppel
- prototype
- provisional
- PTA
- PTA reduction
- PTAB's sua sponte claim construction
- PTE
- PTO Litigation
- public access
- public accessibility
- public availability
- public use
- public use bar
- Publicly available as prior art
- qualitative meaning
- quantitative meaning
- qui tam actions
- range
- ranges
- RCE
- re-examination
- real party in interest
- Reason to combine
- reasonable certainty
- Reasonable Expectation of Success
- reasonable royalty
- recapture
- reduction to practice
- reexamination
- regular and established place of business
- reissue
- Reissue application
- Reissue Claim
- Reissue patent
- Request for Continued Examination
- res judicata
- restriction
- restriction requirement
- Result Effective Variable
- retroactive laws
- right to repair
- royalty
- Rule 19
- rule 4(k)(2)
- rule 60(b)
- Rule of Reason
- safe harbor
- safe harbor rule
- sanctions
- scanner
- Seagate
- secondary considerations
- secondary meaning
- secret use
- Section 101
- section 1400(b)
- Section 2(f) of the Lanham Act
- Section 337
- Self-enabling
- sequence
- significantly more
- Similarity of Marks
- Skilled Artisan
- smartphone
- smoke generating device
- SNQ
- software
- software patent
- software patents
- sovereign immunity
- species
- specific intent
- specification
- specification drafting
- specification examples
- Specimen of Use
- standard of proof
- standard of review
- Standing
- standing to appeal
- standing to appeal IPR decision
- statute of limitations
- statutory estoppel
- strong presumption
- structural limitation
- Subject Matter Eligibility
- Subject Matter Eligibility; § 101
- subject matter jurisdiction
- Substantial evidence
- substantial new question of patentability
- substantial non-infringing use
- substitute claim
- substitution of known elements
- summary judgment
- superfluous
- Supplemental Examination
- supplier exeption
- suppressed
- Supreme Court
- surrender
- tangential exception
- tangential relation
- Teach Away
- teaching away
- technological improvement
- terminal disclaimer
- the Binary Limitation of the Doctrine
- The Supreme Court
- third party use
- Tho
- ThomasBrown
- time-bar
- Time-bar and Privity under § 315(b)
- title
- trade dress
- trade secret
- trade secret misappropriation
- Trademark
- translation
- treatment
- treatment method
- two-year window
- Type A delay
- Type B delay
- Type C delay
- unexpected data
- unexpected result
- unexpected results
- unforseeability
- use in trade
- uses
- utility patent
- validity
- venue
- vitiation
- waiver
- willful blindness
- willful infringement
- willfulness
- writ of mandamus
- written description
- written description requirement
